1Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities[J]. Lancet Oncol, 2007, 8(6): 545-553.
2Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma [ J ]. J Clin Oncol, 2001, 19(2) :305-313.
3Bosset JF, Giguoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus[ J]. N Engl J Med, 1997, 337( 3 ) : 161-167.
4Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus : a randomised controlled phase Ⅲ trial[J]. Lancet Oncol,2005, 6(9):659-668.
5Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis[J]. Lancet Oncol, 2007, 8 (3) : 226-234.
6Mariette C, Piessen G, Lamblin A, et al. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma [ J ]. Br J Surg, 2006, 93 (9) : 1077- 1083.
7Tepper J, Krasna M J, Niedzwiecki D. Phase Ⅲ trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 [J]. J Clin Oncol,2008, 26(7): 1086-1092.
8Crosby TD, Brewster AE, Borley A, et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma[J]. Br J Cancer, 2004, 90(1): 70-75.
9Bedenne L,Michel P,Bouche O,et al. Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus : FFCD 9102[ J ]. J Clin Oncol, 2007, 25(10): 1160-1168.
10Lin Q, Gao XS, Qiao XY, et al. Phase Ⅰ trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer [ J ]. Acta Med Okayama, 2008, 62(1 ) : 37-44.
2Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiotheropy for locally advanced cancers of the esophagus[J]. Int J Radiat Oncol Biol Phys,2001,49(3):657 -664.
3Metges J P. Neo-adjuvant radiochemotherapy for esophageal cancer[J]. Gastroenterol Clin Biol,2006,30(1) :110-113.
4Bray F , Jemal A, Grey N ,et al. Global cancer transitions ac?cording to the human development index (2008 - 2030) : a population - based study[J]. Lancet Oncol, 2012,13 (8) : 790 - 801.
5F okas E , Weiss C, Hodel C. The role of radiotherapy in the multimodal management of esophageal cancer[J] . Dig Dis, 2013,31 (1) :30 - 37.
6Lordick F, Holscher AH, Haustermans K, et al. Multimodal treatment of esophageal cancer[J]. Langenbecks Arch Surg,2013 ,398(2) :177 -187.
7Joel E, Reed CE, Hollis D, et al. Phase III trail of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781[J]. Journal of Clinical Oncology, 2008,26 (7) : 1086 -1089.
8Pretto G, Gurski RR, Binato M, et al. Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus[J]. Dig Dis, 2013,58 (1) : 115 - 122.
9Navarini D, Gurski RR, Aita L, et al. Epidermal growth fac?tor receptor expression in esophageal adenocarcinoma: rela?tionship with tumor stage and survival after esophagectomy[J]. Gastroenterology Research Practice, 2012 , 25 ( 2) : 941 -954.
10Wang HJ , Yao LF , Li XZ. Study on expression of EGFR and c - erbB - 2 of esophageal carcinoma and parallel lymph node metastases[J] . Journal of Practical Oncology, 2007 ,22 (3) :243 -245.
